Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10032762HBVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS10059189HBVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS30014568HIVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS30077154HIVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS30024844HIVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS20068134HPVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS44007688HTLV-1ENSG00000163399.16protein_codingATP1A1YesYes476P05023
TVIS43000129MCVENSG00000163399.16protein_codingATP1A1YesYes476P05023
TCGA Plot Options
Drug Information
GeneATP1A1
DrugBank IDDB01188
Drug NameCiclopirox
Target IDBE0000732
UniProt IDP05023
Regulation Typebinder
PubMed IDs12760852
CitationsNiewerth M, Kunze D, Seibold M, Schaller M, Korting HC, Hube B: Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother. 2003 Jun;47(6):1805-17.
GroupsApproved; Investigational
Direct ClassificationPyridinones
SMILESCC1=CC(=O)N(O)C(=C1)C1CCCCC1
Pathways
PharmGKBPA164747060
ChEMBLCHEMBL1413